Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
Asciminib, an agent that targets the myristoyl pocket of BCR::ABL, was compared with imatinib and with imatinib plus second-generation tyrosine kinase inhibitors. Outcomes were...
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks
In this trial involving 264 hereditary angioedema attacks, oral sebetralstat provided faster times to the beginning of symptom relief, reduction in attack severity, and...
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks
In this trial involving 264 hereditary angioedema attacks, oral sebetralstat provided faster times to the beginning of symptom relief, reduction in attack severity, and...
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks
In this trial involving 264 hereditary angioedema attacks, oral sebetralstat provided faster times to the beginning of symptom relief, reduction in attack severity, and...
